1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ESPERION THERAPEUTICS INC.
Esperion Therapeutics Inc. XNAS: ESPR
1.41 0.00 (0.00%)
1.6M

XNAS 31 Jul, 2025 1:27 PM (EDT)

Board Meeting
The next board meeting for Esperion Therapeutics Inc. is on 05 Aug 2025 for the purpose of Esperion Therapeutics Inc Second Quarter Earnings Results for 2025 See details

Esperion Therapeutics Inc. - ESPR - stock price prediction, stock price target, analyst ratings from 7 analysts

Esperion Therapeutics Inc. has a share price target of US$ 6, revenue growth forecast of 5.5%, and profit growth estimate of 37.0% for FY25, based on top 7 analyst calls.